RainDance's Targeted Sequencing Approach Powers Three Groundbreaking Human Genetic Studies
RainDance Technologies, Inc., a private company pioneering microdroplet-based technologies for single-molecule and single-cell analysis, announced that scientists from The Scripps Research Institute, the Translational Genomics Research Institute (TGen) and Emory University will present data highlighting the broad utility of the company’s innovative microdroplet platform during the 60th Annual Meeting of the American Society of Human Genetics (ASHG). Daniel Salomon, MD, of Scripps, Matthew Huentelman, PhD, of TGen, and Michael Zwick, PhD, of Emory and an ACTSI investigator will present data across diverse human disease research areas including genome-wide association (GWA) follow-on studies, DNA methylation analysis and the identification of X-linked genetic variation. Read more...